AMEX:TRXCSoon enough, you will no longer be able to buy TRXC below 10$. The company develops a disruptive technology and has a massive potential to the upside. It has consistently brought good news in the recent days and weeks. The company has been renamed to Asensus Surgical to reflect the company's broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.
From TA perspective, TRXC had a healthy correction to Fib 50 on daily. And now, it's willing to visit new highs. Target short/mid term is 10,90. Which doesn't mean it's the max it can reach but rather a first target for taking profit. I see it going to the 50$ in the next 2 years.
From TA perspective, TRXC had a healthy correction to Fib 50 on daily. And now, it's willing to visit new highs. Target short/mid term is 10,90. Which doesn't mean it's the max it can reach but rather a first target for taking profit. I see it going to the 50$ in the next 2 years.